
Draxxin® KP (tulathromycin and ketoprofen injection):
A way to fight BRD


Features and benefits
Draxxin KP: One shot. Two ingredients. Fast recovery.
- Ketoprofen controls fever, which may help animals feel better.1*
- Tulathromycin reaches therapeutic levels rapidly and begins to fight against damaging pathogens: Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis.2*
- Low-volume single-dose treatment = fewer injections
- The same dose size and similar viscosity as Draxxin® (tulathromycin injection) Injectable Solution, so you should expect similar year-round syringeability as Draxxin.
- Proven first-time treatment success with Draxxin = less labor and handling time1,2,6*
Treat BRD and control fever effectively
The difference of Draxxin® KP
Important Safety Information
IMPORTANT SAFETY INFORMATION: DRAXXIN KP has a pre-slaughter withdrawal time of 18 days in cattle. Not for use in female dairy cattle 1 year of age or older, including dry dairy cows. Not for use in beef calves less than 2 months of age, dairy calves, and veal calves. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in animals previously found to be hypersensitive to tulathromycin and ketoprofen. See full DRAXXIN KP Prescribing Information.
IMPORTANT SAFETY INFORMATION: KETOFEN has a pre-slaughter withdrawal time of within 48 hours following last treatment. Not for use in female dairy cattle 1 year of age or older, including dry dairy cows. Not for use in beef calves less than 2 months of age, dairy calves, and veal calves. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in animals showing hypersensitivity to ketoprofen. The effects of KETOFEN® on bovine reproductive performance, pregnancy, lactation, or on animals of reproductive age intended for breeding has not been studied. See full KETOFEN Prescribing Information.
References:
1. Data on file, Study Report No. A131C-XC-17-528, Zoetis Inc.
2. Data on file, Study Report No. A431N-US-16-418, Zoetis Inc.
3. Freedom of Information Summary. NADA 141-543 – DRAXXIN® KP (tulathromycin and ketoprofen Injection). Food and Drug Administration; 2020.
4. Data on file, Study Report No. A136R-US-16-508, Zoetis Inc.
5. Data on file, Study Report No. A131C-US-17-531, Zoetis Inc.
6. Poulsen Nautrup B, Van Vlaenderen I, Decker M, Cleale RM. Antimicrobial drug use for control and treatment of bovine respiratory disease in U.S. feedlot cattle: A meta-analysis. Bov Pract. 2017;51(1);1-13.
*Animals treated with Draxxin KP showed numerically improved attitude and respiratory scores compared with animals treated with saline and Draxxin post-treatment.